Development of 7-hydroxy-4-methylcoumarin–cyanoacrylate hybrids with antiproliferative activity against breast cancer cells: from molecular design to in vivo validation
Findings identify compound 8 as a promising antiproliferative and antitumor lead and support further optimization and evaluation of this scaffold in more clinically relevant breast cancer models.
Manar A. El-Zend, I. M. El-Deen, Zeinab Abdelkarim et al.
· RSC Advances · 0 citations